73
Views
1
CrossRef citations to date
0
Altmetric
Practice Pearl

Safety and Efficacy of Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Adjunctive Symptom Relief of Acute Respiratory Infections

, MD, FAAFP
Pages 173-175 | Published online: 13 Mar 2015

References

  • . LaForce C, Gentile DA, Skoner DP. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections. Postgrad Med. 2008;120(2):53–59
  • . Scarupa MD, Kaliner MA. Adjuvant therapies in the treatment of acute and chronic rhinosinusitis. Clin Allergy Immunol. 2007;20:251–262
  • . Benninger MS. Therapeutic choices in the treatment of acute community-acquired bacterial rhinosinusitis. Am J Rhinol. 2006;20(6):662–666
  • . Becker DG. Medical treatment of sinusitis. J Long Term Eff Med Implants. 2003;13(3):195–205
  • . Osguthorpe JD. Adult rhinosinusitis: diagnosis and management. Am Fam Physician. 2001;63(1):69–76
  • . Sharp HJ, Denman D, Puumala S, Leopold DA. Treatment of acute and chronic rhinosinusitis in the United States, 1999–2002. Arch Otolaryngol Head Neck Surg. 2007;133(3):260–265
  • . Taghizadeh F, Hadley JA, Osguthorpe JD. Pharmacological treatments for rhinosinusitis. Expert Opin Pharmacother. 2002;3(3):305–313
  • . Ressel G. Principles of appropriate antibiotic use: Part III. Acute rhinosinusitis. Centers for Disease Control and Prevention. Am Fam Physician. 2001;64(4):685–686
  • . Desrosiers M, Frenkiel S, Hamid QA, . Acute bacterial sinusitis in adults: management in the primary care setting. J Otolaryngol. 2002;31( suppl 2):2S2–14
  • . Rosenfeld RM, Andes D, Bhattacharyya N, . Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg. 2007;137 ( suppl 3):S1–S31
  • . Dicpinigaitis PV, Gayle YE. Effect of guaifenesin on cough reflex sensitivity. Chest. 2003;124(6):2178–2181
  • . Yuta A, Baraniuk JN. Therapeutic approaches to mucus hypersecretion. Curr Allergy Asthma Rep. 2005;5(3):243–251
  • . US Department of Health and Human Services. Expectorant drug products for over-the-counter human use: final monograph. Federal Register. 1989;54:8494–8509
  • . Storms W, Kaliner MA, Javidi M, Farrar J, Efessiou C. A real-world open-label, multicenter, single-group study to evaluate patients' reactions to Mucinex (single-entity long-acting guaifenesin). J Allergy Clin Immunol. 2007;119(1):S229
  • . Eccles R, Jawad MS, Jawad SS, Angello JT, Druce HM. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold. Am J Rhinol. 2005;19(1):25–31
  • . Horak F, Zieglmayer P, Zieglmayer R, . A placebo-controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna Challenge Chamber. Ann Allergy Asthma Immunol. 2009;102(2):116–120
  • . Eccles R. Substitution of phenylephrine for pseudoephedrine as a nasal decongestant. An illogical way to control methamphetamine abuse. Br J Clin Pharmacol. 2007;63(1):10–14
  • . Hatton RC, Winterstein AG, McKelvey RP, Shuster J, Hendeles L. Efficacy and safety of oral phenylephrine: systematic review and meta-analysis. Ann Pharmacother. 2007;41(3):381–390
  • . Mucinex D [package insert]. Parsippany, NJ: Reckitt Benckiser, Inc; 2008
  • . Shi L, Hodges M, Yurgin N, Boye KS. Impact of dose frequency on compliance and health outcomes: a literature review (1966–2006). Expert Rev Pharmacoecon Outcomes Res. 2007;7(2):187–202

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.